Asthma :: Fewer hospitalizations among asthma patients treated with Advair Diskus

An observational study of more than 64,000 asthma patients demonstrated that patients receiving treatment with Advair Diskus (fluticasone propionate and salmeterol inhalation powder) had a significant risk reduction in emergency department visits due to asthma versus patients treated with fluticasone propionate (FP) alone.

Asthma :: Majority of asthma patients remain uncontrolled

A survey of more than 1,300 asthma patients found that the majority of respondents (61 percent) had uncontrolled asthma based on their Asthma Control Test (ACT) score, and nearly one-third (29 percent) of those were not aware that their asthma was uncontrolled. Uncontrolled asthma may place patients at risk for increased symptoms, sudden attacks, hospitalization and even death from asthma.

Lack of understanding about common, life-threatening lung disease that affects millions

Results of a new survey conducted among more than 1,000 Americans age 45 and older reveal that most adults are not concerned about Chronic Obstructive Pulmonary Disease (COPD), a lung disease that is the fourth leading cause of death in the U.S. According to the survey, only 1 in 10 adults could correctly identify what COPD is, and only 4 percent consider COPD to be a health condition they worry ?the most? about getting, compared against other common chronic diseases, such as Alzheimer?s disease, heart disease, diabetes, or lung cancer. However, more people die from COPD than breast cancer or prostate cancer each year.

Asthma :: GlaxoSmithKline welcomes new GINA guidelines for Asthma Management and Prevention

GlaxoSmithKline (GSK) today welcomes new guidelines for Asthma Management and Prevention released today from The Global Initiative for Asthma (GINA). The guidelines emphasise that the overall aim of asthma treatment is to achieve and maintain long-term control of the disease and introduce a new classification of asthma based on levels of control1. Recommended treatment action is then based on the patient?s level of control.

Climate :: Innovative climate protection strategies – Bayer

The Bayer Group has long assigned climate protection top priority and is continuing its activities to improve its greenhouse gas performance. The company welcomes the goal of current government negotiations in Nairobi to achieve a successful global climate protection policy once the commitment period defined in the Kyoto Protocol has come to its conclusion in 2012.

Flu :: Statement – Label changes for Tamiflu – Roche

Tamiflu (oseltamivir phosphate) was demonstrated in clinical trials to be a safe and effective medication for influenza prevention and treatment. Tamiflu was approved in 1999 and has been used by more than 42 million people in over 80 countries.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack